Tolvaptan 15 MG tablet UD 10S
Ended Awarded Last action
- Contract number
- SPE2DR26FJJ9V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,684
Award facts
- Contract value 100% obligated
- $58,683.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 22, 2026, the Defense Logistics Agency awarded a delivery order valued at $58,683.97 to AmerSourceBergen Drug Corp for the supply of Tolvaptan 15 mg tablets in unit dose packages of 10. This firm fixed-price, competitively awarded contract has an ultimate completion date of January 23, 2026 and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract is a child order under AmerSourceBergen's parent company, Cencora, Inc., which holds a substantial $999.9 billion Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX) running through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
This delivery order carries no set-aside designation, indicating it was awarded through open competition. Tolvaptan is a vasopressin receptor antagonist used primarily in the treatment of hyponatremia and polycystic kidney disease, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceutical products to support military treatment facilities and veterans' healthcare programs. AmerSourceBergen's extensive federal contract portfolio demonstrates its critical role as a primary pharmaceutical distributor for the Department of Defense medical supply chain, with capabilities spanning brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FJJ9V?
SPE2DR26FJJ9V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FJJ9V worth?
The government has obligated $58,684 on SPE2DR26FJJ9V.
Is contract SPE2DR26FJJ9V an order under another contract?
Yes. SPE2DR26FJJ9V is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJJ9V competed?
The extent of competition for SPE2DR26FJJ9V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award